Michael Gotthardt at the Max Delbrück Center and collaborators are developing a drug to treat a common type of heart failure ...
Every time Scott publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...
Researchers have developed a mathematical model that can predict the optimum exercise regime for building muscle. Researchers have developed a mathematical model that can predict the optimum exercise ...
This genetic model suggests otherwise, indicating that coupled gating or other mechanical interactions, rather than CICR, drive activation of uncoupled RyR1 channels. Interestingly, the researchers ...
TORONTO--(BUSINESS WIRE)--Satellos Bioscience Inc. (“Satellos” or the “Company”) (TSX: MSCL, OTCQB: MSCLF), a public biotech company developing new small molecule therapeutic approaches to improve the ...
The same model also allows exploration of CICR in neurons, smooth muscle, and immune cells, expanding its clinical impact. With this insight, drug design can now focus on precision control of Ca²⁺ ...